Asok Antony

Division of Hematology-Oncology, Indiana University School of Medicine, United States of America

Asok C. Antony M.D.

Academic positions:
- Professor, Department of Medicine, Division of Hematology/Oncology
- Chief, Hematology-Oncology, Medicine Service
- Richard L. Roudebush Veterans Affairs Medical Center

All industry positions (in last five years):

Research interests:
- Folate Receptors
- Folate Metabolism
- Experimental & Developmental Therapeutics

Any other information:

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Hematology > Anemias & Hypocellular Marrow Disorders (since 10 November 2005)

All recent recommendations

• 9.0
  A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages.
  Recommended by Asok Antony
  
• 6.0
  Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.
  Recommended by Asok Antony
  
• 4.9
  Severe anemia in Malawian children.
  Recommended by Anthony Harries, Arjen Dondorp, Asok Antony
  
• 6.0
  Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
  Recommended by Asok Antony
  
• 3.0
  Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34 cells.
  Recommended by Asok Antony
  
• 6.0
  Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
  Recommended by Asok Antony
  
• 6.4
  Reduction in neural-tube defects after folic acid fortification in Canada.
  Recommended by Takashi Minegishi, Asok Antony
  
• 9.0
  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
  Recommended by Asok Antony
  
• 8.0
  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.
  Recommended by Nicola Low, Asok Antony
  
• 6.5
  Case-control study of human papillomavirus and oropharyngeal cancer.
  Recommended by Asok Antony, Randal Weber, Jacques Bernier
  
• 4.9
  Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
  Recommended by David Goldsmith, Asok Antony, Jurg Schifferli
  Dissent by Giuseppe Remuzzi
• 3.0
  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
  Recommended by Asok Antony
  
• 3.0
  Correction of anemia with epoetin alfa in chronic kidney disease.
  Recommended by Asok Antony
  
• 6.4
  Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.
  Recommended by Charles Lacey, Asok Antony
  
• 6.0
  Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial.
  Recommended by Asok Antony
  
• 4.8
  Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial.
  Recommended by Ruth Gilbert, Asok Antony